ORIGINAL RESEARCH article
Front. Pharmacol.
Sec. Neuropharmacology
Nervonic Acid Confers Neuroprotection in a Zebrafish Model of Diabetic Neuropathy by Promoting Myelin Repair and Metabolic Modulation
Provisionally accepted- 1College of Pharmaceutical Sciences, Zhejiang University, 310058, Hangzhou, China
- 2Hunter BioInsight Technology, Inc., 310051, Hangzhou, China
- 3Hunter Biotechnology, Inc., 310051, Hangzhou, China
- 4Zhejiang Provincial Engineering Research Center for Innovative Small-Molecule Drugs, 321000, Jinhua, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Abstract Introduction Diabetic neuropathy (DN) is one of the most common and debilitating complications of type 2 diabetes mellitus (T2DM), yet effective therapeutic strategies remain limited. Nervonic acid (NA) is recognized for its neuroprotective and anti-inflammatory properties. However, its role in DN has not been fully elucidated. In this study, we investigated the protective effects of NA against T2DM-induced DN using a zebrafish model and explored the underlying molecular mechanisms. Methods T2DM was induced in zebrafish larvae through a high-fat, high-glucose diet combined with a low dose of streptozotocin. Larvae were subsequently treated with NA at concentrations of 125, 250, or 500 μg/mL. Motor function, myelin integrity, neutrophil infiltration, and reactive oxygen species (ROS) levels were evaluated using fluorescence imaging and histological staining. Gene expression analysis was performed by quantitative real-time PCR. Metabolomics coupled with KEGG enrichment analysis was applied to identify NA-regulated metabolic pathways. Results NA significantly preserved myelin integrity, reduced neutrophil infiltration, and lowered ROS levels in DN zebrafish. Expression of myelin-related genes (mbpa and mpz) was upregulated, while pro-inflammatory cytokines were downregulated following NA treatment. Metabolomic profiling revealed that NA reversed diabetes-associated dysregulation in purine metabolism, energy metabolism, vitamin B6 pathways, and redox homeostasis. Key metabolites including guanosine monophosphate, adenosine triphosphate, pyridoxal 5'-phosphate, and L-glutathione were markedly restored toward normal levels. Discussion These findings demonstrate that NA confers robust neuroprotection in DN by alleviating inflammation and oxidative stress, preserving neuronal structure and function, and reprogramming key metabolic pathways.
Keywords: Diabetes neuropathy, Metabolomics, Myelin repair, nervonic acid, Neuroprotection, Oxidative Stress
Received: 09 Oct 2025; Accepted: 02 Feb 2026.
Copyright: © 2026 Huan, Dai, Wang, Cao, Zhu, Guo, Zhang, Wang, Xu and Yu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Yiqiao Xu
Lushan Yu
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
